HIV-1 CONSENSUS B VIF-25 is a short consensus sequence from the Vif protein frequently used to characterize molecular recognition determinants. Its biochemical properties make it suitable for evaluating conformational motifs and interface regions. Researchers apply it in comparative analyses involving variant fragments. The peptide further supports exploration of structural organization within viral accessory proteins.
CAT No: H09527
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More